Clinic
Allina Health System
Allina Health System was paid $22.13M by Medicaid between Jan 2018 and Dec 2024, across 236 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoALLINA HEALTH SYSTEM
COON RAPIDS, MN 55433
COON RAPIDS, MN 55433
33aNPI1295031649assigned 02/02/2011
33bProvider typeClinic/Center
28Total paid$22.13M
24GClaims722,593
24DCodes billed236
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Minnesota
Rank by total paid#2 of 250
Median peer was paid$274K
This provider vs. median81×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TALLARICO, DOMINICA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 131,203 | $1.04M | |
| 2019 | 126,191 | $4.01M | |
| 2020 | 99,027 | $3.41M | |
| 2021 | 134,086 | $4.67M | |
| 2022 | 98,530 | $3.63M | |
| 2023 | 77,577 | $3.06M | |
| 2024incomplete | 55,979 | $2.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 105,399 | 94,495 | $7.24M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 84,917 | 77,574 | $4.22M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.4% | 26,912 | 26,401 | $762K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 10,667 | 10,511 | $746K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.1% | 7,561 | 7,026 | $678K |
| X5622 | 2.9% | 11,601 | 11,110 | $635K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.5% | 9,601 | 9,399 | $558K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 4,444 | 4,296 | $435K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.9% | 5,508 | 5,419 | $424K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.9% | 6,270 | 6,167 | $419K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.8% | 5,021 | 4,887 | $408K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.8% | 6,164 | 3,836 | $401K |
224 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.6% | 5,810 | $349K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.5% | 3,661 | $326K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.0% | 3,105 | $229K |
| 36415 | Collection of venous blood by venipuncture | <1% | 62,049 | $211K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,794 | $188K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,932 | $143K |
| 92015 | Determination of refractive state | <1% | 11,787 | $139K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,956 | $133K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 37,625 | $132K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 5,163 | $131K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 2,605 | $130K |
| 80061 | Lipid panel | <1% | 11,684 | $124K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,528 | $114K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 4,918 | $111K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,571 | $110K |
| 99188 | <1% | 12,998 | $109K | |
| 92551 | <1% | 18,461 | $108K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13,319 | $102K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,291 | $102K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 9,107 | $99K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,688 | $98K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,968 | $92K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,341 | $82K |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 5,644 | $82K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,779 | $73K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,121 | $71K |
| 0002A | <1% | 2,529 | $67K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 1,227 | $66K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,806 | $66K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,320 | $65K |
| 0001A | <1% | 2,596 | $65K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,185 | $61K |
| 90686 | <1% | 15,551 | $59K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,666 | $57K |
| V2020 | Frames, purchases | <1% | 2,046 | $53K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,360 | $50K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,073 | $50K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,341 | $28K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 184 | $27K |
| 80053 | Comprehensive metabolic panel | <1% | 3,093 | $26K |
| 99243 | <1% | 416 | $26K | |
| 92341 | <1% | 947 | $25K | |
| 0054A | <1% | 650 | $25K | |
| 90651 | <1% | 1,608 | $24K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,038 | $21K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,040 | $21K |
| 99177 | <1% | 4,000 | $20K | |
| 0004A | <1% | 635 | $19K | |
| 20610 | <1% | 534 | $19K | |
| 0071A | <1% | 428 | $17K | |
| 99255 | <1% | 129 | $17K | |
| 81001 | <1% | 6,184 | $16K | |
| 82565 | <1% | 3,670 | $15K | |
| 93793 | <1% | 2,012 | $15K | |
| 73630 | <1% | 929 | $15K | |
| 90670 | <1% | 6,620 | $15K | |
| 96127 | <1% | 4,011 | $15K | |
| 0072A | <1% | 360 | $15K | |
| 82728 | <1% | 1,157 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,743 | $14K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 529 | $13K |
| 99173 | <1% | 15,835 | $13K | |
| 84439 | <1% | 1,596 | $13K | |
| 83655 | <1% | 1,272 | $12K | |
| 99205 | Prolong outpt/office vis | <1% | 106 | $12K |
| 80050 | General health panel | <1% | 224 | $11K |
| 87081 | <1% | 3,106 | $11K | |
| 86803 | <1% | 836 | $11K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 318 | $11K |
| 0124A | <1% | 306 | $10K | |
| 97803 | <1% | 253 | $10K | |
| 85027 | <1% | 1,709 | $10K | |
| 85018 | <1% | 4,786 | $10K | |
| 73562 | <1% | 353 | $10K | |
| 86480 | <1% | 179 | $10K | |
| 81025 | <1% | 1,514 | $9K | |
| 99495 | <1% | 65 | $9K | |
| 90785 | <1% | 854 | $9K | |
| 99607 | <1% | 131 | $9K | |
| 36416 | <1% | 3,607 | $9K | |
| 82607 | <1% | 638 | $9K | |
| 99223 | Prolong inpt eval add15 m | <1% | 80 | $8K |
| 80076 | <1% | 1,081 | $8K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 66 | $8K |
| G0008 | Administration of influenza virus vaccine | <1% | 1,278 | $8K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 224 | $7K |
| 84132 | <1% | 1,860 | $7K | |
| 95251 | <1% | 390 | $7K | |
| 93000 | <1% | 893 | $7K | |
| 82947 | <1% | 2,361 | $7K | |
| 90715 | <1% | 995 | $7K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 961 | $7K |
| 87210 | <1% | 1,588 | $6K | |
| 84460 | <1% | 1,534 | $6K | |
| 90480 | <1% | 247 | $6K | |
| 90694 | <1% | 208 | $6K | |
| 86140 | <1% | 1,179 | $6K | |
| 90656 | <1% | 771 | $5K | |
| 82043 | <1% | 992 | $5K | |
| 91322 | <1% | 45 | $5K | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 792 | $5K |
| 86780 | <1% | 409 | $5K | |
| 85610 | <1% | 1,275 | $4K | |
| 99460 | <1% | 77 | $4K | |
| 90653 | <1% | 206 | $4K | |
| 92567 | <1% | 547 | $4K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 56 | $4K |
| 90716 | <1% | 2,622 | $4K | |
| 0082A | <1% | 106 | $4K | |
| 90691 | <1% | 382 | $4K | |
| 83540 | <1% | 519 | $3K | |
| 99383 | <1% | 35 | $3K | |
| 73030 | <1% | 201 | $3K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 59 | $3K |
| 84295 | <1% | 780 | $3K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 588 | $3K |
| 99384 | <1% | 32 | $3K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 326 | $3K |
| 99605 | <1% | 51 | $3K | |
| 80047 | <1% | 222 | $3K | |
| 0052A | <1% | 68 | $3K | |
| 81514 | <1% | 12 | $3K | |
| 87186 | <1% | 448 | $3K | |
| 0051A | <1% | 66 | $3K | |
| 92557 | <1% | 119 | $3K | |
| 90717 | <1% | 219 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 52 | $3K |
| 90837 | Psychotherapy session, about an hour | <1% | 29 | $3K |
| 81003 | <1% | 1,434 | $3K | |
| 84450 | <1% | 609 | $2K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 121 | $2K |
| 94060 | <1% | 115 | $2K | |
| 72100 | <1% | 82 | $2K | |
| 90707 | <1% | 2,213 | $2K | |
| 99385 | <1% | 29 | $2K | |
| 87481 | <1% | 56 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 56 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 13 | $2K |
| 73610 | <1% | 147 | $2K | |
| 17110 | <1% | 25 | $2K | |
| 82310 | <1% | 394 | $2K | |
| 83550 | <1% | 204 | $2K | |
| 85652 | <1% | 744 | $2K | |
| 87340 | <1% | 161 | $2K | |
| 87338 | <1% | 105 | $2K | |
| 90732 | <1% | 16 | $1K | |
| 0081A | <1% | 43 | $1K | |
| 90734 | <1% | 1,393 | $1K | |
| 99442 | <1% | 353 | $1K | |
| 87077 | <1% | 192 | $1K | |
| 73560 | <1% | 98 | $1K | |
| 82435 | <1% | 354 | $1K | |
| 84520 | <1% | 393 | $1K | |
| 0154A | <1% | 31 | $1K | |
| 94010 | <1% | 68 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 182 | $1K |
| 87088 | <1% | 164 | $1K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 83 | $882.46 |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 39 | $856.91 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | $812.33 |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 25 | $802.02 |
| 83718 | <1% | 137 | $744.21 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 26 | $731.37 |
| 82248 | <1% | 168 | $697.40 | |
| 99443 | <1% | 99 | $679.75 | |
| 86762 | <1% | 66 | $672.02 | |
| 82247 | <1% | 130 | $617.70 | |
| 99401 | <1% | 216 | $612.66 | |
| 86735 | <1% | 67 | $609.38 | |
| 73120 | <1% | 28 | $608.01 | |
| 86765 | <1% | 66 | $601.70 | |
| 86787 | <1% | 66 | $601.70 | |
| 96380 | <1% | 39 | $595.32 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 14 | $581.79 |
| 90723 | <1% | 5,309 | $575.13 | |
| 0083A | <1% | 13 | $557.38 | |
| 0074A | <1% | 14 | $499.24 | |
| 83690 | <1% | 69 | $473.62 | |
| 82465 | <1% | 152 | $464.74 | |
| 77080 | <1% | 15 | $425.70 | |
| 86704 | <1% | 53 | $412.04 | |
| 74019 | <1% | 15 | $400.32 | |
| 94729 | <1% | 17 | $380.61 | |
| 86706 | <1% | 54 | $378.57 | |
| 92133 | <1% | 14 | $372.98 | |
| 99402 | <1% | 93 | $360.61 | |
| 92370 | <1% | 26 | $342.80 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 37 | $332.38 |
| 0003A | <1% | 14 | $305.06 | |
| 86200 | <1% | 24 | $301.06 | |
| 90713 | <1% | 30 | $298.87 | |
| 82040 | <1% | 58 | $282.61 | |
| 83735 | <1% | 41 | $265.63 | |
| 90714 | <1% | 12 | $260.24 | |
| 84075 | <1% | 45 | $256.94 | |
| 74018 | <1% | 12 | $254.64 | |
| 90647 | <1% | 4,948 | $205.61 | |
| 86431 | <1% | 38 | $202.89 | |
| 92587 | <1% | 12 | $188.81 | |
| 84480 | <1% | 12 | $181.66 | |
| 84155 | <1% | 43 | $171.40 | |
| 99441 | <1% | 48 | $144.79 | |
| 90633 | <1% | 3,298 | $141.80 | |
| 90688 | <1% | 102 | $138.00 | |
| 87467 | <1% | 44 | $136.76 | |
| 84550 | <1% | 29 | $129.19 | |
| 82784 | <1% | 13 | $127.60 | |
| 90696 | <1% | 466 | $113.44 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 15 | $50.27 |
| 90700 | <1% | 578 | $21.89 | |
| 90677 | <1% | 664 | $15.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $0.95 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 16 | $0.24 |
| 90681 | 0% | 2,094 | $0.00 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | 0% | 34 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 80 | $0.00 |
| 91300 | 0% | 374 | $0.00 | |
| V5266 | Battery for use in hearing device | 0% | 13 | $0.00 |
| 73110 | 0% | 13 | $0.00 | |
| 90672 | 0% | 14 | $0.00 | |
| 91307 | 0% | 49 | $0.00 | |
| 90632 | 0% | 17 | $0.00 | |
| 90381 | 0% | 13 | $0.00 | |
| 99000 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTALLARICO, DOMINICA (COO)
| Provider | Location | Paid |
|---|---|---|
| Allina Health System | Saint Paul, MN | $118.02M |
| Allina Health System | Minneapolis, MN | $18.26M |
| Allina Health System | Cambridge, MN | $13.17M |
| Allina Health System | St Paul, MN | $10.77M |
| Allina Health System | Faribault, MN | $7.56M |
| Allina Health System | New Ulm, MN | $7.47M |
| Allina Health System | Fridley, MN | $7.34M |
| Allina Health System | Woodbury, MN | $5.49M |
| Allina Health System | Minneapolis, MN | $5.35M |
| Allina Health System | Bloomington, MN | $4.38M |
| Allina Health System | Northfield, MN | $4.36M |
| Allina Health System | Hastings, MN | $4.22M |
| Allina Health System | Maplewood, MN | $4.15M |
| Allina Health System | West St Paul, MN | $3.64M |
| Allina Health System | Cottage Grove, MN | $3.63M |
| Allina Health System | Minneapolis, MN | $3.54M |
| Allina Health System | Eagan, MN | $3.39M |
| Allina Health System | St Paul, MN | $3.35M |
| Allina Health System | Shakopee, MN | $2.81M |
| Allina Health System | Eden Prairie, MN | $2.71M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.